Transkaryotic Therapies - Ownership and Business Overview

Life ScienceCompany

Transkaryotic Therapies Ownership

Who owns Transkaryotic Therapies?

Transkaryotic Therapies is owned by Shire. It was acquired on April 28, 2005.

Transkaryotic Therapies Business Overview

Where is Transkaryotic Therapies headquartered?

Transkaryotic Therapies is headquartered in Cambridge, Massachusetts.

What sector is Transkaryotic Therapies in?

Transkaryotic Therapies is a life science company.

Life Science M&A Summary in 2005

Out of 60 sectors in the Mergr database, life science ranked 13 in number of deals in 2005. The largest life science acquisition in 2005 was Ivax - which was acquired by Teva Pharmaceutical Industries for $7.4B.

Join Mergr to view all 78 acquisitions of life science companies in 2005, including 18 acquisitions by private equity firms, and 60 by strategics.

Transkaryotic Therapies, Inc.

700 Main Street,
Cambridge, Massachusetts 02139
United States,
(617) 349-0200

Transkaryotic Therapies, Inc. (TKT) is a biopharmaceutical company dedicated to the development and commercialization of products based on its three proprietary development platforms: Gene-Activated proteins, Niche Protein products and Gene Therapy.


 Subscribe to unlock this and 207,502
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.